The industrial genomic revolution: A new era in neuroimmunology

Rotem Shalita, Ido Amit

Research output: Contribution to journalReview articlepeer-review


Recent discoveries have highlighted the importance of understanding the complex interactions between the brain and immune systems in health and neurodegenerative disease. In this Primer, we outline single-cell multiomics approaches. Applied to patient samples with rich metadata, functional organoids, and animal models, single-cell studies will facilitate the next big leap in translational neuro-immune research. We believe this will pave the way for reshaping our understanding of the neuro-immune interplay: from descriptive to functional, from broad cell types to effective pathways, spatial organization, biomarkers, and targets, toward a comprehensive mechanistic understanding that will be the impetus for drug discovery and therapeutic breakthroughs. We envision that in the near future, single-cell multiomics technologies, along with the advances in immunotherapy development, will become a major driving force and fully integrated resource in the toolset for the development of therapeutic agents in neuroimmunology, which will revolutionize drug development for treating neurodegenerative diseases.

Original languageEnglish
Pages (from-to)3429-3443
Number of pages15
Issue number21
Early online date17 Oct 2022
StatePublished - 2 Nov 2022

All Science Journal Classification (ASJC) codes

  • General Neuroscience


Dive into the research topics of 'The industrial genomic revolution: A new era in neuroimmunology'. Together they form a unique fingerprint.

Cite this